Peptide Profiles of Women Undergoing Breast Biopsy
Completed
Conditions studied: Breast Cancer
In brief
This study is being done to learn about blood proteins. We want to see if the blood proteins in women whose biopsies show breast cancer are different from the blood proteins in women whose biopsies do not show breast cancer. The goal of this study is to develop a blood test than can help detect breast cancers when they are very small and easy to cure.
Key facts
- Study ID
- NCT00587821
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 571
- Starts
- 2006-01-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2013-12-19
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female
- Age ≥ or = to 18
- Cohort A: Biopsy Cohort:
- Referred by a healthcare provider for breast biopsy
- No prior history of invasive breast cancer OR of ductal carcinoma in situ
- No prior history of other malignancies within 5 years except cervical dysplasia, squamous cell carcinoma of the skin or basal cell carcinoma of the skin Cohort B: Metastatic Disease Cohort - Diagnosis of stage IV breast cancer
You may not qualify if…
- Male
- Age < 18
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.